Bioanalysis

1.6(top 50%)

impact factor

2.5K(top 10%)

papers

44.2K(top 10%)

citations

71(top 10%)

h-index

1.8(top 50%)

extended IF

3.5K

all documents

46.1K

doc citations

102(top 10%)

g-index

Top Articles

#	Title	Journal	Year	Citations
1	The importance of experimental design and QC samples in large-scale and MS-driven untargeted metabolomic studies of humans	Bioanalysis	2012	382
2	The effect of hematocrit on assay bias when using DBS samples for the quantitative bioanalysis of drugs	Bioanalysis	2010	269
3	Microfluidic 3D cell culture: potential application for tissue-based bioassays	Bioanalysis	2012	268
4	Matrix effects and application of matrix effect factor	Bioanalysis	2017	268
5	Advances in metabolite identification	Bioanalysis	2011	238
6	Hemato-critical issues in quantitative analysis of dried blood spots: challenges and solutions	Bioanalysis	2013	213
7	MALDI imaging mass spectrometry: bridging biology and chemistry in drug development	Bioanalysis	2011	212
8	Stable-isotope dilution LC–MS for quantitative biomarker analysis	Bioanalysis	2010	206
9	Bioanalytical assay strategies for the development of antibody–drug conjugate biotherapeutics	Bioanalysis	2013	205
10	A device for dried blood microsampling in quantitative bioanalysis: overcoming the issues associated blood hematocrit	Bioanalysis	2015	173
11	Stable isotope-labeling studies in metabolomics: new insights into structure and dynamics of metabolic networks	Bioanalysis	2014	171
12	Immunoaffinity chromatography: an introduction to applications and recent developments	Bioanalysis	2010	161
13	EBF recommendation on the validation of bioanalytical methods for dried blood spots	Bioanalysis	2011	157
14	Isothermal DNA amplification in bioanalysis: strategies and applications	Bioanalysis	2011	151
15	Surrogate matrix and surrogate analyte approaches for definitive quantitation of endogenous biomolecules	Bioanalysis	2012	150
16	The effect of hematocrit and punch location on assay bias during quantitative bioanalysis of dried blood spot samples	Bioanalysis	2011	147
17	Bioanalysis of antibody–drug conjugates: American Association of Pharmaceutical Scientists Antibody–Drug Conjugate Working Group position paper	Bioanalysis	2013	144
18	Bioanalytical approaches to analyzing peptides and proteins by LC–MS/MS	Bioanalysis	2011	142
19	Analytical techniques for metabolomic studies: a review	Bioanalysis	2019	129
20	Salting-out assisted liquid–liquid extraction for bioanalysis	Bioanalysis	2013	128
21	Pharmacokinetic considerations as to when to use dried blood spot sampling	Bioanalysis	2010	126
22	Incurred sample reanalysis (ISR): a decisive tool in bioanalytical research	Bioanalysis	2011	120
23	Matrix effect elimination during LC–MS/MS bioanalytical method development	Bioanalysis	2009	118
24	Nano-LC in proteomics: recent advances and approaches	Bioanalysis	2015	118
25	LC–MS/MS-based quantification of kynurenine metabolites, tryptophan, monoamines and neopterin in plasma, cerebrospinal fluid and brain	Bioanalysis	2016	113
26	The effect of hematocrit on bioanalysis of DBS: results from the EBF DBS-microsampling consortium	Bioanalysis	2013	112
27	Analytical protocols based on LC–MS, GC–MS and CE–MS for nontargeted metabolomics of biological tissues	Bioanalysis	2014	112
28	New US FDA draft guidance on bioanalytical method validation versus current FDA and EMA guidelines: chromatographic methods and ISR	Bioanalysis	2014	107
29	Sample treatment based on extraction techniques in biological matrices	Bioanalysis	2011	106
30	State-of-the-art dried blood spot analysis: an overview of recent advances and future trends	Bioanalysis	2013	105
31	Computational strategies for metabolite identification in metabolomics	Bioanalysis	2009	103
32	Update of the EBF recommendation for the use of DBS in regulated bioanalysis integrating the conclusions from the EBF DBS-microsampling consortium	Bioanalysis	2013	103
33	Recent advances in metabolite identification and quantitative bioanalysis by LC–Q-TOF MS	Bioanalysis	2012	99
34	Characterization of the drug-to-antibody ratio distribution for antibody–drug conjugates in plasma/serum	Bioanalysis	2013	98
35	Pellet digestion: a simple and efficient sample preparation technique for LC–MS/MS quantification of large therapeutic proteins in plasma	Bioanalysis	2012	97
36	In vitro and in vivo characterizations of PEGylated liposomal doxorubicin	Bioanalysis	2011	96
37	Large-volume centrifugal microfluidic device for blood plasma separation	Bioanalysis	2010	93
38	Mechanisms of amine accumulation in, and egress from, lysosomes	Bioanalysis	2009	91
39	Capillary microsampling of 25 µl blood for the determination of toxicokinetic parameters in regulatory studies in animals	Bioanalysis	2012	91
40	Microfluidic paper-based analytical devices: from POCKET to paper-based ELISA	Bioanalysis	2011	90
41	Microfluidic paper-based devices for bioanalytical applications	Bioanalysis	2014	90
42	Metabolomics: an integral technique in systems biology	Bioanalysis	2010	89
43	Challenges in urine bioanalytical assays: overcoming nonspecific binding	Bioanalysis	2010	88
44	Therapeutic monoclonal antibody concentration monitoring: free or total?	Bioanalysis	2010	86
45	Incurred sample reproducibility: views and recommendations by the European Bioanalysis Forum	Bioanalysis	2009	85
46	Replacing immunoassays with tryptic digestion-peptide immunoaffinity enrichment and LC–MS/MS	Bioanalysis	2012	85
47	The 2nd Calibration and Validation Group Workshop on recent issues in Good Laboratory Practice bioanalysis	Bioanalysis	2009	84
48	Current strategies for coping with the hematocrit problem in dried blood spot analysis	Bioanalysis	2014	83
49	Analytical pitfalls and challenges in clinical metabolomics	Bioanalysis	2016	83
50	Sample preparation prior to the LC–MS-based metabolomics/metabonomics of blood-derived samples	Bioanalysis	2011	82

Scientometrics

Overviews

Citing Bodies

Bioanalysis

Top Articles